Filter Gallery Category: More Gray
18AE – More Gray
45-year-old patient with a history of untreated or inadequately managed psoriasis, with no significant improvement from topical treatments (e.g., corticosteroids
PC39
A 39 -year-old male patient with psoriasis vulgaris presented with less pink plaques with slight scaling on the extensor surface
PC38
A patient with pustular psoriasis presented with purple plaque on the abdomen with pustules and crust.
PC37
56-year-old male patient with psoriasis vulgaris. Presented with multiple purple plaques with thick scales on the front of his chest
PC36
60-year-old male patient with psoriasis vulgaris. Presented with thick scaled gray plaques on both arms and trunk.
<div class="addtoany_share_save_container addtoany_content
What's New
First-Line Biologics in Psoriasis: Evidence from the BADBIR Cohort Study
In this IPC commentary, Matias Maskin examines evidence from the BADBIR registry demonstrating that first-line biologic therapy in moderate to severe psoriasis leads to faster skin clearance, improved quality of life, and a lower risk of comorbidities. The analysis challenges traditional step-up approaches and supports earlier, patient-centered treatment strategies.
Highlights from the 2026 American Academy of Dermatology (AAD) Annual Meeting: Diagnostic Complexity, Therapeutic Advances, and Emerging Research
What were the key takeaways from the 2026 AAD Annual Meeting? IPC shares updates on diagnostic challenges, psoriasis therapies, and late-breaking research from leading experts.
International Collaboration Announced to Improve Care for Psoriasis and Psoriatic Arthritis in Latin America
A new regional collaboration led by IPC and partner organizations aims to improve diagnosis, treatment, and care coordination for psoriasis and psoriatic arthritis across Latin America.
Next Generation of Leaders: 2025 IPC Fellows Transition to Jr. Councilors
IPC recognizes its 2025 Fellows as IPC Jr. Councilors following the completion of their fellowship. This transition recognizes their contributions to psoriasis research, education, and global collaboration, and marks their expanded role in the IPC network.
IPC Welcomes New Councilors Dr. Mari Løset and Dr. Maxwell Sauder
The International Psoriasis Council welcomes Mari Løset and Maxwell Sauder as new Councilors, supporting IPC’s global mission in psoriasis research and care.
Recent Advances in Psoriasis: A Year in Review
In this Take Ten with IPC video, Dr. Leandro Leite discusses the most recent advances in psoriasis over the last year (March 2025 – March 2026). Topics include new guidelines, research, and recent studies.